Total Payments
$3,879
2024 Payments
$589.59
Companies
34
Transactions
231
Medicare Patients
2,172
Medicare Billing
$195,853
Payment Breakdown by Category
Food & Beverage$3,879 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,879 | 231 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $441.82 | 31 | $0 (2024) |
| Novo Nordisk Inc | $351.93 | 21 | $0 (2024) |
| GlaxoSmithKline, LLC. | $350.74 | 21 | $0 (2024) |
| Abbott Laboratories | $278.51 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $260.12 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $218.24 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $208.66 | 13 | $0 (2022) |
| Amgen Inc. | $193.64 | 12 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $178.77 | 12 | $0 (2022) |
| ACADIA Pharmaceuticals Inc | $158.17 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $589.59 | 26 | ACADIA Pharmaceuticals Inc ($118.75) |
| 2023 | $553.46 | 34 | Lilly USA, LLC ($159.87) |
| 2022 | $767.95 | 47 | Novo Nordisk Inc ($133.65) |
| 2021 | $556.50 | 32 | Novo Nordisk Inc ($89.96) |
| 2020 | $261.58 | 18 | Boehringer Ingelheim Pharmaceuticals, Inc. ($57.28) |
| 2019 | $242.95 | 17 | Lilly USA, LLC ($43.12) |
| 2018 | $407.18 | 27 | AstraZeneca Pharmaceuticals LP ($99.60) |
| 2017 | $499.32 | 30 | Horizon Pharma plc ($85.72) |
All Payment Transactions
231 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.49 | General |
| Category: Cardio-renal | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2024 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $18.05 | General |
| Category: Rare Disease | ||||||
| 10/07/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: Diabetes | ||||||
| 08/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: RESPIRATORY | ||||||
| 08/01/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.76 | General |
| Category: Endocrinology | ||||||
| 07/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Diabetes | ||||||
| 07/23/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 07/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: Diabetes Care | ||||||
| 07/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes Care | ||||||
| 07/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: VACCINES | ||||||
| 07/11/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $13.09 | General |
| Category: VACCINE | ||||||
| 05/29/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Cardio-renal | ||||||
| 03/07/2024 | PFIZER INC. | TRUMENBA (Biological), PREVNAR 20, COMIRNATY | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: VACCINES | ||||||
| 02/15/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/14/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Diabetes | ||||||
| 02/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes Care | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $21.21 | General |
| Category: Respiratory | ||||||
| 01/23/2024 | ACADIA Pharmaceuticals Inc | DAYBUE (Drug) | Food and Beverage | In-kind items and services | $118.75 | General |
| Category: RETT SYNDROME | ||||||
| 01/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.59 | General |
| Category: RESPIRATORY | ||||||
| 01/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 613 | 760 | $117,258 | $54,176 |
| 2022 | 9 | 494 | 671 | $114,764 | $52,124 |
| 2021 | 16 | 556 | 690 | $105,237 | $49,950 |
| 2020 | 11 | 509 | 602 | $94,517 | $39,603 |
Total Patients
2,172
Total Services
2,723
Medicare Billing
$195,853
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 145 | 266 | $54,796 | $20,928 | 38.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 113 | 113 | $20,905 | $13,638 | 65.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 96 | 113 | $15,820 | $6,265 | 39.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 71 | 71 | $7,526 | $5,104 | 67.8% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 15 | 17 | $9,129 | $3,491 | 38.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 73 | 73 | $3,066 | $2,116 | 69.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 15 | $3,615 | $1,635 | 45.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 53 | 56 | $1,400 | $470.40 | 33.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 12 | 13 | $702.00 | $450.06 | 64.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 21 | 23 | $299.00 | $78.43 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 160 | 319 | $65,714 | $25,199 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 88 | 88 | $16,280 | $10,922 | 67.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 63 | 67 | $7,102 | $4,563 | 64.2% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 16 | 19 | $10,203 | $3,991 | 39.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 47 | 50 | $7,000 | $2,828 | 40.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 19 | $4,579 | $2,392 | 52.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 69 | $2,898 | $1,890 | 65.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 18 | 18 | $702.00 | $263.72 | 37.6% |
| 81002 | Urinalysis, manual test | Office | 2022 | 20 | 22 | $286.00 | $75.66 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 140 | 257 | $52,942 | $20,844 | 39.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 85 | 85 | $15,725 | $10,802 | 68.7% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 16 | 20 | $10,740 | $4,093 | 38.1% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 59 | 61 | $6,466 | $3,942 | 61.0% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 22 | 22 | $2,640 | $2,639 | 100.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 28 | $3,920 | $1,596 | 40.7% |
About Dr. Kent Rhodes, M.D
Dr. Kent Rhodes, M.D is a Internal Medicine healthcare provider based in Baker, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972553196.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kent Rhodes, M.D has received a total of $3,879 in payments from pharmaceutical and medical device companies, with $589.59 received in 2024. These payments were reported across 231 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($3,879).
As a Medicare-enrolled provider, Rhodes has provided services to 2,172 Medicare beneficiaries, totaling 2,723 services with total Medicare billing of $195,853. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Pediatrics
- Location Baker, LA
- Active Since 05/10/2006
- Last Updated 05/28/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1972553196
Products in Payments
- JARDIANCE (Drug) $299.15
- Ozempic (Drug) $233.38
- TRELEGY ELLIPTA (Drug) $218.60
- Kerendia (Drug) $218.24
- FREESTYLE LIBRE 3 (Device) $183.55
- FARXIGA (Drug) $167.69
- XARELTO (Drug) $164.54
- DAYBUE (Drug) $158.17
- TRULICITY (Drug) $137.25
- MOUNJARO (Drug) $91.26
- Rybelsus (Drug) $89.34
- JANUVIA (Drug) $89.12
- VIMOVO (Drug) $85.72
- EVENITY (Biological) $83.86
- INJECTAFER (Drug) $77.30
- EMGALITY (Drug) $73.39
- LINZESS (Drug) $71.33
- SHINGRIX (Biological) $63.11
- Vascepa (Drug) $63.06
- VRAYLAR (Drug) $62.32
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.